High-risk pituitary adenomas and strategies for predicting response to treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-risk pituitary adenomas and strategies for predicting response to treatment
Authors
Keywords
-
Journal
Hormones-International Journal of Endocrinology and Metabolism
Volume 21, Issue 1, Pages 1-14
Publisher
Springer Science and Business Media LLC
Online
2022-01-21
DOI
10.1007/s42000-021-00333-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preoperative prediction of granulation pattern subtypes in GH‐secreting pituitary adenomas
- (2021) Lijun Heng et al. CLINICAL ENDOCRINOLOGY
- Aggressive pituitary tumors in the young and elderly
- (2020) Christina Tatsi et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours ( PitNET )s
- (2020) Federica Guaraldi et al. CLINICAL ENDOCRINOLOGY
- Somatostatin receptor profile in pituitary thyrotroph adenomas
- (2020) Eleni Thodou et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomas
- (2020) Yae Won Park et al. Pituitary
- Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly
- (2020) Amy A. Swanson et al. Pituitary
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas
- (2019) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
- (2019) G Giuffrida et al. Endocrine Connections
- Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
- (2019) Anna Kathrin Stueven et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A tale of pituitary adenomas: to NET or not to NET
- (2019) Ken K. Y. Ho et al. Pituitary
- MGMT immunohistochemistry in pituitary tumors: controversies with clinical implications
- (2019) George Kontogeorgos et al. Pituitary
- Is MGMT the best marker to predict response of temozolomide in aggressive pituitary tumors? Alternative markers and prospective treatment modalities
- (2019) George Kontogeorgos et al. Hormones-International Journal of Endocrinology and Metabolism
- A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal
- (2019) C. Villa et al. VIRCHOWS ARCHIV
- The Clinicopathological Spectrum of Acromegaly
- (2019) Amit Akirov et al. Journal of Clinical Medicine
- Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution
- (2019) Sylvia L. Asa et al. Pituitary
- Aggressive and malignant pituitary tumours: state-of-the-art
- (2018) Dorota Dworakowska et al. ENDOCRINE-RELATED CANCER
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
- (2018) Alexander S. G. Micko et al. Pituitary
- Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
- (2018) Luis V. Syro et al. Frontiers in Endocrinology
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Giant Prolactinomas
- (2018) Ilan Shimon NEUROENDOCRINOLOGY
- Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre
- (2018) S Asioli et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review
- (2017) Hormones-International Journal of Endocrinology and Metabolism
- Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection
- (2017) Waseem Touma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
- (2017) Alexander S. G. Micko et al. Pituitary
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly
- (2016) Iulia Potorac et al. ENDOCRINE-RELATED CANCER
- Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
- (2016) Ozgur Mete et al. MODERN PATHOLOGY
- How effective is temozolomide for treating pituitary tumours and when should it be used?
- (2016) Carmel Halevy et al. Pituitary
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores
- (2015) Evanthia Diakatou et al. CLINICAL ENDOCRINOLOGY
- The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
- (2015) Hiroshi Nishioka et al. ENDOCRINE PATHOLOGY
- Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth
- (2015) E. Delgrange et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Macroprolactinomas in Children and Adolescents: Factors Associated With the Response to Treatment in 77 Patients
- (2015) Sylvie Salenave et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Aggressive Pituitary Tumors
- (2015) Eleftherios Chatzellis et al. NEUROENDOCRINOLOGY
- Primary Medical Treatment of Thyrotropin–Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients
- (2015) Frédérique Rimareix et al. THYROID
- THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas
- (2014) Dominique Maiter et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
- (2014) Olga Moshkin et al. Hormones-International Journal of Endocrinology and Metabolism
- Silent Corticotroph Adenomas After Stereotactic Radiosurgery: A Case–Control Study
- (2014) Zhiyuan Xu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy
- (2014) Youwei Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Management of aggressive pituitary adenomas and pituitary carcinomas
- (2014) Anthony Heaney JOURNAL OF NEURO-ONCOLOGY
- Aggressive pituitary adenomas—diagnosis and emerging treatments
- (2014) Antonio Di Ieva et al. Nature Reviews Endocrinology
- Invasive adenoma and pituitary carcinoma: a SEER database analysis
- (2014) Tara M. Hansen et al. NEUROSURGICAL REVIEW
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
- (2013) Marie Batisse et al. CANCER INVESTIGATION
- mTOR is Frequently Active in GH-Secreting Pituitary Adenomas without Influencing their Morphopathological Features
- (2013) Emir Ahmed Sajjad et al. ENDOCRINE PATHOLOGY
- Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas
- (2013) Sarah Larkin et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
- (2013) Bernhard Mayr et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- Therapeutic implications of accurate classification of pituitary adenomas
- (2013) Ozgur Mete et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
- (2012) Gou Mizutani et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting
- (2012) Meike Körner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinicopathological Correlations in Pituitary Adenomas
- (2012) Ozgur Mete et al. BRAIN PATHOLOGY
- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- Temozolomide in aggressive pituitary adenomas and carcinomas
- (2012) LD Ortiz et al. Clinics
- Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
- (2012) Jessica Brzana et al. Pituitary
- Somatostatin analogs for the treatment of neuroendocrine tumors
- (2011) Michael D. Culler et al. CANCER AND METASTASIS REVIEWS
- Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
- (2011) Masako Kato et al. ENDOCRINE JOURNAL
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Therapy of aggressive pituitary tumors
- (2011) Annamaria Colao et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
- (2011) Fateme Salehi et al. JOURNAL OF NEURO-ONCOLOGY
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- MGMT Immunoexpression in Silent Subtype 3 Pituitary Adenomas: Possible Therapeutic Implications
- (2010) Michael E. Fealey et al. ENDOCRINE PATHOLOGY
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pathology, Pathogenesis and Therapy of Growth Hormone (GH)-producing Pituitary Adenomas: Technical Advances in Histochemistry and Their Contribution
- (2009) Robert Y. Osamura et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas
- (2009) Toru TATENO et al. ENDOCRINE JOURNAL
- Clinicopathological Characterization of TSH-Producing Adenomas: Special Reference to TSH-immunoreactive but Clinically Non-functioning Adenomas
- (2009) Elaine Lu Wang et al. ENDOCRINE PATHOLOGY
- Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
- (2009) Anat Ben-Shlomo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
- (2008) D. Erickson et al. CLINICAL ENDOCRINOLOGY
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form
- (2008) Abdulkader Obari et al. ENDOCRINE PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started